VivoSeq
Other

Gastrointestinal Endoscopy

0

Pipeline Programs↗

1

Active Trials↗

2

Companies Involved↗

Gastrointestinal Endoscopy is an early-stage landscape with 0 programs across 2 companies. The most active players are Nihon Pharmaceutical Co., Ltd, AstraZeneca.

Intelligence

Pipeline Metrics

Competitive Density

6/100

Pipeline Velocity

11/100

Mech. Concentration

N/A

Completion Rate

100/100

Attrition Rate

0/100

Competition

Competitive Landscape

Bubble size = clinical trials

Approved
Phase 3
Phase 2
Phase 1
Preclinical

Key Players

Top Companies Companies ranked by the number of pipeline programs they run for this disease.

N

Nihon Pharmaceutical Co., Ltd

0 programs

PreclinicalAstraZeneca logo

AstraZeneca

0 programs

Preclinical

Pipeline

Programs by Phase

No pipeline programs currently tracked for this disease.

Analysis

Trial Status

8

clinical trials

Completed5 · 63%
Unknown status2 · 25%
Not yet recruiting1 · 13%

Clinical Trials

Trial Activity

8 trials

Ketodex Versus Ketofol in Adolescent Gastrointestinal Endoscopy
Not yet recruiting·GGiresun University·N/A·NCT07401914·90 enrolled
Nebulized Dexmedetomidine as a Premedication for Gastrointestinal Endoscopy in Pediatric Patients
Completed·OOndokuz Mayıs University·N/A·NCT06218797·108 enrolled
Study of NPO-11 in Patients Undergoing Gastrointestinal Endoscopy
Completed·NNihon Pharmaceutical Co., Ltd·Phase 3·NCT03263910·220 enrolled
Comparison Between Remimazolam Tosilate and Midazolam in Elderly Patients Undergoing Gastrointestinal Endoscopy
Completed·PPeking University People's Hospital·N/A·NCT04656964·353 enrolled
Respiratory Safety of Oliceridine During Sedated Gastrointestinal Endoscopy
Completed·—·N/A·NCT07187765·508 enrolled
Phase III Study of ICI35,868 (Diprivan) With and Without EES0000645/A (SDS) on Gastrointestinal Endoscopy
Completed·AstraZeneca logoAstraZeneca·Phase 3·NCT01961349·279 enrolled
Remimazolam Improves the Safety in Elderly Patients Undergoing Gastrointestinal Endoscopy
Unknown status·FFirst Affiliated Hospital Xi'an Jiaotong University·Phase 4·NCT05406102·300 enrolled
Propofol Versus Midazolam for Lower Gastrointestinal Endoscopy
Unknown status·—·Phase 3·NCT03388151·100 enrolled

Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)